During the past decade, Hôpital des Enfants conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 18 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 12 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital des Enfants" #1 sponsor was "University Hospital, Toulouse" with 12 trials, followed by "Centre Oscar Lambret" with 6 trials sponsored, "Actelion" with 5 trials sponsored, "Ipsen" with 4 trials sponsored and "Centre Hospitalier Intercommunal Creteil" with 4 trials sponsored. Other sponsors include 52 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital des Enfants" #1 collaborator was "Association Clinique Thérapeutique Infantile du val de Marne" with 3 trials as a collaborator, "Ligue contre le cancer, France" with 3 trials as a collaborator, "National Cancer Institute, France" with 3 trials as a collaborator, "Cystic Fibrosis Foundation" with 2 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 39 different institutions and companies that were collaborators in the rest 47 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital des Enfants" are "Cystic Fibrosis" (4 trials), "Duchenne Muscular Dystrophy" (4 trials), "Leukemia" (4 trials), "Pulmonary Arterial Hypertension" (4 trials) and "Neuroblastoma" (3 trials). Many other conditions were trialed in "Hôpital des Enfants" in a lesser frequency.

Most popular intervention types in "Hôpital des Enfants" are "Drug" (56 trials), "Other" (18 trials), "Procedure" (7 trials), "Biological" (4 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Etoposide" (4 trials), "Ataluren" (3 trials), "cytarabine" (3 trials) and "etoposide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital des Enfants" are 80 trials for "All" genders, 5 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are 34 active trials in "Hôpital des Enfants". 1 are not yet recruiting, 21 are recruiting, 10 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 39 completed trials in Hôpital des Enfants, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital des Enfants, 7 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 15 trials that are defined as “Not Applicable".